Plasma cells from multiple myeloma patients express PD-L1 and increase expression after stimulation with IFN-γ and TLR ligands via a myeloid differentiation primary response gene 88/tumor necrosis factor receptor associated factor 6 (MYD88/TRAF6)-, MEK-dependent pathway (51). The gene discussed is MYD88; the disease is plasma cell myeloma.